BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND KRAS, C-K-RAS, 3845, P01116, NS3, KI-RAS, KRAS2, K-RAS4A, K-RAS2A, K-RAS4B, KRAS1, K-RAS2B, RASK2 AND Diagnosis
115 results:

  • 1. Response of a Novel KANK1::ALK Fusion to Alectinib in an Advanced Lung Adenocarcinoma: A Case Report.
    Tang Q; Li T; Ren F; Li X; Cao W; Yu H; Mao F; Cao C; Zu L; Xu S
    J Natl Compr Canc Netw; 2024 Feb; 22(2):. PubMed ID: 38364363
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. 2021 WHO Classification of Lung Cancer: Molecular Biology Research and Radiologic-Pathologic Correlation.
    Sasaki T; Kuno H; Hiyama T; Oda S; Masuoka S; Miyasaka Y; Taki T; Nagasaki Y; Ohtani-Kim SJ; Ishii G; Kaku S; Shroff GS; Kobayashi T
    Radiographics; 2024 Mar; 44(3):e230136. PubMed ID: 38358935
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Histiocytic sarcoma following CAR T-cell therapy: a case report.
    An K; He Y; Tang Y; Gu X; Qian J; Li B
    Int J Hematol; 2024 Mar; 119(3):338-341. PubMed ID: 38294639
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Demographics and additional haematologic cancers of patients with histiocytic/dendritic cell neoplasms.
    Kemps PG; Kester L; Scheijde-Vermeulen MA; van Noesel CJM; Verdijk RM; Diepstra A; van Marion AMW; Dors N; van den Bos C; Bruggink AH; Hogendoorn PCW; van Halteren AGS
    Histopathology; 2024 Apr; 84(5):837-846. PubMed ID: 38213281
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Transcriptome analysis of primary adult B-cell lineage acute lymphoblastic leukemia identifies pathogenic variants and gene fusions, and predicts subtypes for in depth molecular diagnosis.
    Podgorica M; Drivet E; Viken JK; Richman A; Vestbøstad J; Szodoray P; Kvam AK; Wik HS; Tjønnfjord GE; Munthe LA; Frietze S; Schjerven H
    Eur J Haematol; 2024 May; 112(5):731-742. PubMed ID: 38192186
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. [Clinical and molecular biological characterization of patients with accelerated chronic lymphocytic leukemia].
    Zhou ZY; Dai LMJ; Sha YQ; Qiu TL; Qin SC; Miao Y; Xia Y; Wu W; Tang HN; Xu W; Li JY; Zhu HY
    Zhonghua Xue Ye Xue Za Zhi; 2023 Nov; 44(11):917-923. PubMed ID: 38185521
    [No Abstract]    [Full Text] [Related]  

  • 7. [Clinical Analysis of Infants with Acute Lymphoblastic Leukemia (18 cases)].
    Li KL; Xiong H; Li H; Wang Z; Chen Z; Yang L; Lu WJ; Qi SS; Sun M
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Dec; 31(6):1670-1675. PubMed ID: 38071044
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genomic Profiling of Primary Diffuse Large B-Cell lymphoma of the Central Nervous System Suggests Novel Potential Therapeutic Targets.
    Agostinelli C; Morandi L; Righi S; Cirillo L; Iommi M; Tonon C; Mazzatenta D; Zoli M; Rossi M; Bagnato G; Broccoli A; Lodi R; Zinzani PL; Sabattini E; Giannini C; Asioli S
    Mod Pathol; 2023 Dec; 36(12):100323. PubMed ID: 37678673
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
    Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
    Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Testicular Rosai-Dorfman disease clonally related to CMML - Case report and literature review.
    Fiegl A; Dirnhofer S; Juskevicius D; Zagrapan B; Dertinger S; Bösl A; Milos S; Brunner J; Bertolini F; Offner FA
    Pathol Res Pract; 2023 Jul; 247():154548. PubMed ID: 37216748
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Changes of tumor microenvironment in non-small cell lung cancer after TKI treatments.
    Chen S; Tang J; Liu F; Li W; Yan T; Shangguan D; Yang N; Liao D
    Front Immunol; 2023; 14():1094764. PubMed ID: 36949948
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Trends in Survival Rates of Non-Small Cell Lung Cancer With Use of Molecular Testing and Targeted Therapy in Korea, 2010-2020.
    Chi SA; Yu H; Choi YL; Park S; Sun JM; Lee SH; Ahn JS; Ahn MJ; Choi DH; Kim K; Jung HA; Park K
    JAMA Netw Open; 2023 Mar; 6(3):e232002. PubMed ID: 36929402
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Spectrum and clinical features of gene mutations in Chinese pediatric acute lymphoblastic leukemia.
    Shen D; Liu L; Xu X; Song H; Zhang J; Xu W; Zhao F; Liang J; Liao C; Wang Y; Xia T; Wang C; Lou F; Cao S; Qin J; Tang Y
    BMC Pediatr; 2023 Feb; 23(1):62. PubMed ID: 36739388
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Genomics improves risk stratification of adults with T-cell acute lymphoblastic leukemia enrolled in measurable residual disease-oriented trials.
    González-Gil C; Morgades M; Lopes T; Fuster-Tormo F; García-Chica J; Zhao R; Montesinos P; Torrent A; Diaz-Beya M; Coll R; Hermosín L; Mercadal S; González-Campos J; Zamora L; Artola T; Vall-Llovera F; Tormo M; Gil-Cortés C; Barba P; Novo A; Ribera J; Bernal T; De Ugarriza PL; Queipo MP; Martínez-Sánchez P; Giménez A; González-Martínez T; Cladera A; Cervera J; Fernández-Martín R; Ardaiz MÁ; Vidal MJ; Baena Á; López-Bigas N; Bigas A; Maciejewski J; Orfao A; Ribera JM; Genescà E
    Haematologica; 2023 Apr; 108(4):969-980. PubMed ID: 36325893
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Genetic correlation of crizotinib efficacy and resistance in ALK- rearranged non-small-cell lung cancer.
    Liu C; Liu C; Liao J; Yin JC; Wu X; Zhao X; Sun S; Wang H; Hu Z; Zhang Y; Yu H; Shao Y; Wang J
    Lung Cancer; 2022 Sep; 171():18-25. PubMed ID: 35870258
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. High early death rates, treatment resistance, and short survival of Black adolescents and young adults with AML.
    Larkin KT; Nicolet D; Kelly BJ; Mrózek K; LaHaye S; Miller KE; Wijeratne S; Wheeler G; Kohlschmidt J; Blachly JS; Mims AS; Walker CJ; Oakes CC; Orwick S; Boateng I; Buss J; Heyrosa A; Desai H; Carroll AJ; Blum W; Powell BL; Kolitz JE; Moore JO; Mayer RJ; Larson RA; Stone RM; Paskett ED; Byrd JC; Mardis ER; Eisfeld AK
    Blood Adv; 2022 Oct; 6(19):5570-5581. PubMed ID: 35788257
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Targeting molecular alterations in non-small-cell lung cancer: what's next?
    López-Castro R; García-Peña T; Mielgo-Rubio X; Riudavets M; Teixidó C; Vilariño N; Couñago F; Mezquita L
    Per Med; 2022 Jul; 19(4):341-359. PubMed ID: 35748237
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Detection of
    Yao YL; Wang XG; Zhao XL; Li SQ; Zhou YJ; Xu YZ
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Mar; 24(3):309-313. PubMed ID: 35351263
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. The Application of NextGen Sequencing in the diagnosis of Myeloid Neoplasms in Myeloma Patients With Cytopenia.
    Song J; Zhang H; Dong N; Zhang X; Hussaini M; Jain A; Moscinski L; Shain K; Baz R; Alsina M; Nishihori T; Zhang L
    Clin Lymphoma Myeloma Leuk; 2022 Jun; 22(6):e414-e426. PubMed ID: 34998786
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Resistance of B-Cell lymphomas to CAR T-Cell Therapy Is Associated With Genomic Tumor Changes Which Can Result in Transdifferentiation.
    Laurent C; Syrykh C; Hamon M; Adélaïde J; Guille A; Escudié F; Jalowicki G; Fina F; Bardet A; Mescam L; Molina TJ; Dartigues P; Parrens M; Sujobert P; Besson C; Birnbaum D; Xerri L
    Am J Surg Pathol; 2022 Jun; 46(6):742-753. PubMed ID: 34799485
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 6.